ConductScience.org, home

Paper8092834

Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.

Martin E and 2 others. Antimicrob Agents Chemother, 1994. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum. Papers, record 8092834. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8092834

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1994
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
2
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martin EE
2Maier FF
3Bhakdi SS

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amphotericin BMajor topic
Blood Physiological PhenomenaMajor topic
Candida albicansMajor topic
FluconazoleMajor topic
FlucytosineMajor topic
Flow Cytometry
Humans

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15394441A pharmacologic guide to the clinical use of amphotericin B.J Infect Dis1969https://conductscience.org/library/papers/5394441PubMed
24550505Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).Proc Natl Acad Sci U S A1972https://conductscience.org/library/papers/4550505PubMed
31097545Synergism of amphotericin B and 5-fluorocytosine for candida species.J Infect Dis1975https://conductscience.org/library/papers/1097545PubMed
459892Letter: Antagonism between miconazole and amphotericin B.Lancet1976https://conductscience.org/library/papers/59892PubMed
5789783Rubidium release: a rapid and sensitive assay for amphotericin B.J Infect Dis1976https://conductscience.org/library/papers/789783PubMed
6338264Synergism of polyene antibiotics with 5-fluorocytosine.Chemotherapy1978https://conductscience.org/library/papers/338264PubMed
7646348Amphotericin B pharmacokinetics in humans.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/646348PubMed
8361901In vitro studies of amphotericin B in combination with the imidazole antifungal compounds clotrimazole and miconazole.J Infect Dis1978https://conductscience.org/library/papers/361901PubMed
97195793Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.Chemotherapy1981https://conductscience.org/library/papers/7195793PubMed
106286784Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics.J Infect Dis1982https://conductscience.org/library/papers/6286784PubMed
116295266Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6295266PubMed
126297871Antifungal agents used in systemic mycoses. Activity and therapeutic use.Drugs1983https://conductscience.org/library/papers/6297871PubMed
136299182Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6299182PubMed
146338821Mechanisms of action of 5-fluorocytosine.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6338821PubMed
156307124Antifungal agents useful in therapy of systemic fungal infections.Annu Rev Pharmacol Toxicol1983https://conductscience.org/library/papers/6307124PubMed
166522917Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis.Rev Infect Dis1984https://conductscience.org/library/papers/6522917PubMed
173977211Amphotericin B resistance in Candida.Ann Intern Med1985https://conductscience.org/library/papers/3977211PubMed
183906911Combined ketoconazole and amphotericin B treatment of acute disseminated histoplasmosis in a renal allograft recipient.South Med J1985https://conductscience.org/library/papers/3906911PubMed
193512734Effects of serum lipoproteins on damage to erythrocytes and Candida albicans cells by polyene antibiotics.J Infect Dis1986https://conductscience.org/library/papers/3512734PubMed
203528319Effects of sublethal concentrations of amphotericin B on Candida albicans.J Infect Dis1986https://conductscience.org/library/papers/3528319PubMed

See all 45 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
35348983Multicenter prospective observational study of fungal keratitis in Japan: analyses of in vitro susceptibility tests for combinations of drugs.Jpn J Ophthalmol2022https://conductscience.org/library/papers/35348983PubMed
27415801NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning.PLoS Comput Biol2016https://conductscience.org/library/papers/27415801PubMed
25685044The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms.Saudi Pharm J2015https://conductscience.org/library/papers/25685044PubMed
14982754Combination antifungal therapy.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/14982754PubMed
11158745
Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11158745PubMed
10582869Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10582869PubMed
10582868
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10582868PubMed
10103187LY303366 exhibits rapid and potent fungicidal activity in flow cytometric assays of yeast viability.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10103187PubMed
9756757Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single-cell level.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9756757PubMed
9624480Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9624480PubMed
8913455In vitro interaction between amphotericin B and azoles in Candida albicans.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8913455PubMed
8818910Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests.J Clin Microbiol1996https://conductscience.org/library/papers/8818910PubMed
8540690Use of amphotericin B with azole antifungal drugs: what are we doing?Antimicrob Agents Chemother1995https://conductscience.org/library/papers/8540690PubMed
7793858Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7793858PubMed
7751374Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay.J Clin Microbiol1995https://conductscience.org/library/papers/7751374PubMed
7492096In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7492096PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8092834

GET https://conductscience.org/api/papers/v1/8092834/references?page=2